MedTrace Logo

Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes

NCT07177404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2026-04-29

No results posted yet for this study

Summary

Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous glucose monitor) and uses an algorithm to tell an insulin pump how much insulin to deliver. Hybrid closed-loop has currently been rolled out to many people with type 1 diabetes in England. We are keen to develop a deeper understanding of the perspective of people living with type 1 diabetes who have choices about which hybrid closed-loop systems fit their needs.

The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.

Conditions

  • Diabete Mellitus
  • Type 1 Diabetes Mellitus

Sponsors & Collaborators

  • University of Nottingham

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-04
Primary Completion
2026-02-26
Completion
2026-02-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07177404 on ClinicalTrials.gov